Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia

Philip D. Hall, Gabriel Virella, Tony Willoughby, Daniel H. Atchley, Robert J. Kreitman, Arthur E. Frankel

Simmons Comprehensive Cancer Center
Hematology & Oncology
Internal Medicine

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia

Fingerprint

Medicine & Life Sciences